Volume 21 - Issue 12 - December, 2009

Percutaneous Aortic Valve Implantation in Patients with Coronary Artery Disease: Review of Therapeutic Strategies

From the †Department of Cardiology, Rabin Medical Center, Petach Tikva, and the 'Sackler' Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, ‡Onassis Cardiac Surgery Centre, 1st Cardiology Department, Athens, Greece.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted July 6, 2009, provisional acceptance given July 20. 2009, and final version accepted July 27, 2009.

Address for correspondence: Prof. R. Kornowski, Department of Cardiology, Rabin Medical Center, Petach Tikva 49100, Israel. E-mail: [email protected]



Chinese “Firebird” Brand Sirolimus-eluting Stent Fracture

From the Department of Cardiology, Shanghai Minhang District Central Hospital, Shanghai, China.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted May 4, 2009, provisional acceptance given June 23, 2009, final version accepted July 15, 2009.

Address for correspondence: Wei Hu, Department of Cardiology, Minhang District Central Hospital, 201100, Shanghai, China. E-mail: [email protected]

_______________________________________________

ABSTRACT: Recently, a stent fracture (SF) was reported as



Spontaneous Coronary Artery Dissection-A Diagnosis To Be Considered in Young Patients (Full title below)

Spontaneous Coronary Artery Dissection — A Diagnosis To Be Considered in Young Patients Presenting with Acute Myocardial Infarction

From the ‡Emergency Department, Hospital de Messejana, Fortaleza, Brazil, *Haemodynamics, Hospital Mont Klinikum, Fortaleza, Brazil, †Haemodynamics, Hospital de Messejana, Fortaleza, Brazil.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted April 1, 2009, provisional acceptance given April 27, 2009, final version accepted May 4, 2009.

Address for correspondence: Rafael N. Macedo, E



Preprocedural Inflammation Does Not Affect Neointimal Hyperplasia following Everolimus-Eluting Stent Implantation

ABSTRACT: Background. Preprocedual C-reactive protein (CRP) has been reported to correlate with in-stent restenosis following bare-metal stent implantation. The aim of this study was to investigate the impact of preprocedural inflammation on neointimal hyperplasia assessed by intravascular ultrasound (IVUS) following everolimus-eluting stent (EES) implantation. Methods. We identified 134 patients meeting the following criteria: 1) patients treated with EES; 2) those with stable or unstable angina; and 3) patients available for high-sensitivity (hs)-CRP before the procedure and volumetric IVUS



Management of Guidewire-Induced Coronary Artery Perforations through Transradial Route-A Simple Approach

From the †Total Cardiovascular Solutions Private Limited, and Sheth V.S.General Hospital, Ahmedabad, India.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted June 19, 2009, provisional acceptance given July 20, 2009, final version accepted August 3, 2009.

Address for correspondence: Tejas Patel, MD, FACC, FSCAI, Professor and Head, Department of Cardiology, Sheth V.S.General Hospital, Ahmedabad-380 006, India. E-mail: [email protected]

_______________________________________________



Validation of a Risk Score for Target Vessel Revascularization after Coronary Stent Implantation

ABSTRACT: Objective. Our aim was to validate a risk score for new target vessel revascularization (TVR) after bare-metal stent (BMS) implantation. Methods. The risk score was developed in a cohort of patients previously treated with BMS at our institution. This risk score ranges from 0 to 5 points, according to the presence of diabetes mellitus (1 point), reference vessel diameter (> 3.5 mm = 0 points; 3–3.5 mm = 1; < 3 mm = 2) and lesion length (≤ 10 mm = 0 points; 10–20 mm = 1; > 20 mm = 2). Patients included in the validation cohort were treated between January and December 2005. Pati



Very Late Thrombosis of a Sirolimus-Eluting Stent after 57 Months

From the *University of Miami Miller School of Medicine, and Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, and §Nova Southeastern College of Medicine, Ft. Lauderdale, Florida.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted May 29, 2009, provisional acceptance given June 24, 2009, final version accepted July 7, 2009.

Address for correspondence: Anil Paturi, MD, Internal Medicine Residency Program, JFK Medical Center, 4 South, 5301 S. Congress, Atlantis, FL 33462. E-mail: apaturi@me



A Novel “In-Situ Tulip-Bud Deployment” Method for Transcatheter Closure of Secundum Atrial Septal Defect

ABSTRACT: Objective. We devised a new technique for interventional closure of atrial septal defect (ASD) using the Amplatzer Septal Occluder (ASO), and validated this by comparing it with a cohort using the conventional method. Background. Transcatheter closure of ASD is a widely accepted modality of treatment. Although the outcome is good, there are occasional technical difficulties encountered. Method. In this three-step technique, the device is protruded to form a “tulip bud.” This “tulip bud” is then aligned adjacent to and along the plane of the ASD. The second step involves withd